Sarah Sammons, MD

Video

ESMO25 Breast Cancer Highlights: monarchE and NATALEE

Harold Burstein, MD, PhD, and Sarah Sammons, MD, discuss the monarchE and NATALEE trials, investigating CDK4/6 inhibitors for high-risk, early stage, HR+ breast cancer.